INTRODUCTION
============

*Caprine herpesvirus* type 1 (CpHV-1) is an α-herpesvirus of goats sharing several biological behaviours with human herpesvirus type 2 (HHV-2), i.e., genital lesions, latency in sacral ganglia \[[@R1]\]. CpHV-1 is responsible for systemic lethal infections in kids \[[@R2]\] and respiratory or genital infections in adult goats \[[@R3]\]. CpHV-1 can be isolated from the nose and/or vagina of infected animals. Natural or experimental infection may occur both *via* nasal and/or genital route \[[@R4],[@R5]\]. When the virus infects goats by the nose, the infection can spread throughout the body and reach the genital mucosa. The infection by the vaginal route remains restricted to the genital tract \[[@R4],[@R6]\]. No differences have been observed among nasal or vaginal isolates using virus neutralization test. Italian, Swiss, American and Spanish CpHV-1 strains, have been analysed by Restriction Fragment Length Polymorphism (RFLP), showing differences in the restriction patterns: i.e. altered sizes of single fragments, lacking or additional fragments \[[@R7]-[@R9]\].

In order to evaluate genomic diversity of the isolates, nucleotide and amino acid sequences of glycoprotein C (gC), were analyzed in thirteen CpHV-1 strains.

MATERIAL AND METHODS
====================

Strains
-------

Thirteen CpHV-1 strains were analyzed in this study: eight vaginal and five nasal isolates. As reported in Table **[1](#T1){ref-type="table"}**, the viruses were isolated in natural or experimental reactivations of CpHV-1 in geographically and timely different caprine flocks.

Extraction of Viral DNA
-----------------------

DNA was extracted from the original nasal and vaginal samples using the Qiamp Tissue Kit (Qiagen GmbH, Germany) according to the instructions of the manufacturer and stored at +4°C.

Amplification of gC Gene
------------------------

The glycoprotein C gene was amplified by polymerase chain reaction (PCR). Primers (Nik1 and Nik2) specific for CpHV-1 \[[@R10]\] and internal primers (CB3F and CB3R) were used for the amplification of 1800 bp and 400 bp fragment respectively of the gC gene. The internal primers were used to point out the short sequence repeats (SSR), as reported in Table **[2](#T2){ref-type="table"}**.

The total volume of the PCR reaction was 50µl, which contained 10-50ng extracted DNA, 1X buffer (100mM Tris-HCl, pH 8.3 and 500mM KCl), 25mM MgCl~2~, 1.25mM dNTP, 50pmol of each primer and 1.25 units of *TaKaRa LA Taq^TM^* (TAKARA BIO INC.) in distilled water. The PCR programme was 94°C for 1 min (*TaKaRa LA Taq^TM^* activation temperature), followed by 35 cycles of 1 min and 30 sec at 95°C, 1,00 min at 60°C and 2 min and 30 sec at 72°C, and it was terminated with an extension at 72°C for 10 min (Thermocycler Applied Biosystems Gene Amp PCR system 9700). The PCR products were electrophoresed in 1.4% agarose gels (Ambion) in TAE buffer and visualised under UV light after ethidium bromide staining (10mg/ml). GeneRuler^*TM*^ 50 bp DNA Ladder (Fermentas) was used as molecular weight standard.

Sequence Analysis
-----------------

The PCR products were purified in Ultrafree-DA columns (Amicon, Millipore) and sequenced using the Taq DyeTerminator Cycle Sequencing Kit (Applied Biosystems) with an ABIPRISM 377. Sequences were aligned for the same strain. The nucleotide and amino acid sequences were read using the analytical tools by the National Center for Biotechnology Information (NCBI) and align by the program CLUSTALW and FASTA \[[@R11]\].

RESULTS
=======

PCR products had a size ranging from 400 bp to 464 bp using primers CB3F and CB3R. The amplified fragments show that the nucleotide sequences had a different molecular weight as described in Fig. (**[1](#F1){ref-type="fig"}**).

The nucleotide sequences of the amplified products showed a variable number of short sequence repeats (SSR), each containing 15 nucleotides, among the examined strains: 4 SSR in one strain (nasal), 2 SSR in seven strains (n.5 vaginal, n.2 nasal) and 1 SSR in three strains (n.2 vaginal, n.1 nasal). Two strains had no SSR (n.1 vaginal, n.1 nasal), (Table **[3](#T3){ref-type="table"}**). At the protein level, the SSR corresponded to the amino acid stretch FEDSA, ENDGA, KEDGA or KEDSA on the basis of the analyzed strain (Fig. **[2](#F2){ref-type="fig"}**).

DISCUSSION
==========

The SSR in the family of *Herpesviridae* genomes play diverse roles, including modulating gene expression as contingency loci, facilitating genome rearrangements *via* recombination and affecting protein structure and possibly protein-protein interactions \[[@R12]-[@R16]\]. Genetic variations and classification into different genogroups have been described for other herpesviruses, such as bovine herpesvirus type 1 (BHV-1), \[[@R17]\], varicella-zoster virus \[[@R18]\], simian varicella virus \[[@R19]\] Epstein-Barr virus \[[@R20],[@R21]\], cytomegalovirus \[[@R22],[@R23]\], and human herpesviruses 6 and 7 \[[@R24],[@R25]\]. As reported by Norberg *et al.* \[[@R26]\], DNA sequencing of large regions from the clinical HHV-1 isolates may be helpful in revealing genetic alterations associated with HHV-1 pathogenesis and may be used for molecular epidemiology studies of different viral populations as well as for studies of single patient isolates and to investigate the role of homologous recombination in the evolution of the HHV-1 genome.

Nucleotide and amino acid sequence analysis indicate that CpHV-1 isolates have genetic diversity in the gC gene according to the number of SSR detected (4 SSR of 60 bp in one strain, 2 SSR of 30 bp in seven strains and 1 SSR of 15 bp in three strains). Variable regions containing SSR have been also reported in HHV-1 \[[@R27],[@R28]\]. On the basis of few information available, it may be supposed that CpHV-1 isolates are characterized by high G+C content and presence of nucleotides repeats in the sequences of glycoprotein C gene. Genetic rearrangements (SSR) in the gC gene, may be useful for differentiation of CpHV-1 strains as reported for feline herpesvirus type 1 (FeHV-1) \[[@R29]\] and further studies will also elucidate whether the SSR number is related to any biological feature of CpHV-1 i.e. the nasal or the vaginal tropism.
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![PCR products of CpHV-1 strains using two internal primers (CB3F-CB3R) of gC gene. Lanes 1, 3, 6, 9, 12, 15, 18: 50 bp DNA ladder plus (Fermentas); lane 2: Carica (464 bp); lane 4: Ba-3 (433 bp); lane 5: Ba-2 (449 bp); lane 7: 2760 (436 bp); lane 8: 5175 (437 bp); lane 10: Ba-6 (432 bp); lane 11: TV16 (430 bp); lane 13: Usa (434 bp); lane 14: Sicilia (428 bp); lane 16: 1347 (419 bp); lane 17: Svizzero (415 bp); lane 19: Ba-1 (405 bp); lane 20: TN7 (400 bp).](TOVJ-4-85_F1){#F1}

![Alignment of the glycoprotein C (gC) gene. It is possible to observe the short sequence repeats (SSR) drawn based on the number of insertions. Box shows the SSR. Carica has 4 SSR, Ba-3, Ba-2, 2760, 5175, Ba-6, TV16 and USA 2 SSR, Sicilia, 1347 and Svizzero 1 SSR; Ba-1 and TN7 have no SSR.](TOVJ-4-85_F2){#F2}

###### 

CpHV-1 Strains Used in this Study

  Strains            Recovery   Origin
  ------------------ ---------- ---------------------------
  **1. Carica**      nose       Experimental reactivation
  **2. Ba-3**        nose       Experimental reactivation
  **3. Ba-2**        vagina     Experimental reactivation
  **4. 2760**        vagina     Natural reactivation
  **5. 5175**        vagina     Natural reactivation
  **6. Ba- 6**       vagina     Experimental reactivation
  **7. TV 16**       vagina     Experimental reactivation
  **8. Usa**         nose       Experimental reactivation
  **9. Sicilia**     vagina     Experimental reactivation
  **10. 1347**       vagina     Natural reactivation
  **11. Svizzero**   nose       Experimental reactivation
  **12. Ba-1**       vagina     Experimental reactivation
  **13. TN 7**       nose       Experimental reactivation

###### 

Primers Sequences

  --------------------------------------------------
  Nik1 (forward) 5' -gCTAgggCTCTgCACgTC- 3'
  Nik2 (reverse) 5' - gCCATTgAAAgggTTACgTC- 3'
  CB3F (forward) 5' -AgTTgACgTACAACgggTCggCgTA- 3'
  CB3R (reverse) 5' - AgAgCAgCgAAgAgggCgACgA- 3'
  --------------------------------------------------

###### 

Analysis of gC Gene of CpHV-1 Strains

  Number of Strains   Number of Short Sequence Repeats (SSR)   Total of Inserted Nucleotides (bp)   Sampling Origin
  ------------------- ---------------------------------------- ------------------------------------ ------------------------
  1                   4                                        60                                   nasal
  7                   2                                        30                                   n.5 vaginal, n.2 nasal
  3                   1                                        15                                   n.2 vaginal, n.1 nasal
  2                   0                                        \-                                   n.1 vaginal, n.1 nasal
